Dr Wechalekar is a Reader in Medicine and Haematology at University College London/University College London Hospital/Royal Free Hospital, London, UK. After medical training in India, he completed his haematology training in the UK. His interest in plasma cell disorders started with a fellowship in myeloma at the Princess Margaret Hospital, Toronto. He leads the AL amyloidosis program in the UK with clinical and research is used on plasma cell disorders particularly AL amyloidosis. His research interests including the development of better risk stratification of the disease, reducing early cardiac mortality in AL, imaging, clonal biology and new treatment strategies in AL amyloidosis. He leads on a number of national and international clinical trials in AL amyloidosis and myeloma at UCL and has published extensively in the respective areas.
You can see my upcoming and previous webinars here.
